Hospital or health organisation · founded 1891
Methodist Hospital
Omaha, United States · bestcare.org/methodist-hospital
- Citations, last 5 years
- 902
- Works, last 5 years
- 74
- h-index
- 81
- Scientists listed
- 0
- Grants since 2016
- 211
Grants received
2023–2027 · research · R01
Human Atherogenesis with Underlying Dysfunctional HDL-Free Cholesterol
Khurram Nasir · Methodist Hospital · funded by National Institutes of Health
2023–2028 · research · R01
Regulation of Cell Death in HIV Reservoirs
Jin Wang · Methodist Hospital · funded by National Institutes of Health
2023–2028 · research · R01
Cardiac Autonomic Activation In Atrial Fibrillation Triggers And Substrate
Francisco Altamirano · Methodist Hospital · funded by National Institutes of Health
2023–2028 · research · R01
Quantitation of nutrient metabolism in brain tumor patients using advanced 13C isotopomer technology
Kumar Pichumani · Methodist Hospital · funded by National Institutes of Health
2023–2028 · research · R01
Transforming Curiosity into Donation: Validating a Risk Prediction Index to Detect and Prevent Drop-Out in Potential Living Kidney Donors who are Racial/Ethnic Minorities
Amy Doggette Waterman · Methodist Hospital · funded by National Institutes of Health
2023–2028 · research · R33
VENOUS ETHANOL ABLATION IN ISCHEMIC VENTRICULAR TACHYCARDIA- VELVET TRIAL
Miguel Valderrabano · Methodist Hospital · funded by National Institutes of Health
2023–2028 · research · R01
Proteomics based mapping of cardiac extracellular matrix to define sex and age-dependent changes.
Katarzyna A. Cieslik · Methodist Hospital · funded by National Institutes of Health
2023–2028 · research · R01
Clinical Impact of the Cefazolin Inoculum Effect
Cesar Augusto Arias · Methodist Hospital · funded by National Institutes of Health
2023–2026 · research · R01
Central and peripheral immune cross-talk in Alzheimer's disease and their modulation by a novel immunotherapy
Alireza Faridar · Methodist Hospital · funded by National Institutes of Health
2023–2028 · research · R01
Mechanisms of STING in malignant progression and therapy of CLL.
Chih-Chi Andrew Hu · Methodist Hospital · funded by National Institutes of Health
2023–2028 · research · R01
Induction of autosis to overcome resistance in adoptive cell therapy for solid tumors
Yong Lu · Methodist Hospital · funded by National Institutes of Health
2023–2028 · research · R35
Landscapes for Cell State Transition Leveraging by Single-Cell Multi-Omics
Guangyu Wang · Methodist Hospital · funded by National Institutes of Health
2022–2027 · research · R01
Ultra-long Acting Transcutaneously Refillable Islatravir Nanofluidic Implant for HIV Pre-Exposure
Alessandro Grattoni · Methodist Hospital · funded by National Institutes of Health
2022–2027 · research · R01
XBP1 Inhibition and STING activation for the treatment of cancer
Juan R Del Valle · Methodist Hospital · funded by National Institutes of Health
2022–2027 · research · R01
XBP1 Inhibition and STING activation for the treatment of cancer
Juan R Del Valle · Methodist Hospital · funded by National Institutes of Health
2022–2026 · research · R01
Vascularized Islet transplantation NICHE with local immunosuppression for the treatment of type 1 diabetes
Alessandro Grattoni · Methodist Hospital · funded by National Institutes of Health
2022–2023 · research · R21
Exploring the role of ER Beta in disease penetrance in individuals with Li-Fraumeni syndrome
Christoforos Thomas · Methodist Hospital · funded by National Institutes of Health
2022–2027 · cooperative agreement · U01
A phase II multi-center trial evaluating dual targeting of the PI3K/AKT and NOS pathways for treating metaplastic breast cancer (MpBC)
Jenny C-N Chang · Methodist Hospital · funded by National Institutes of Health
2022–2027 · research · R01
Vascularized NICHE with local immunosuppression for cell replacement for Type 1 diabetes
Alessandro Grattoni · Methodist Hospital · funded by National Institutes of Health
2022–2027 · training · T32
T32 Administrative Supplement
Philip J Horner · Methodist Hospital · funded by National Institutes of Health
2022–2027 · training · T32
Training in Neural Control of organ Degeneration and Regeneration (NeuralCODR)
Philip J Horner · Methodist Hospital · funded by National Institutes of Health
2022–2027 · research · R01
Mechanisms driving cardiac dysfunction in Autosomal Dominant Polycystic Kidney Disease
Francisco Altamirano · Methodist Hospital · funded by National Institutes of Health
2022–2027 · research · R01
Mechanisms driving cardiac dysfunction in Autosomal Dominant Polycystic Kidney Disease
Francisco Altamirano · Methodist Hospital · funded by National Institutes of Health
2022–2027 · cooperative agreement · U01
A phase II multi-center trial evaluating dual targeting of the PI3K/AKT and NOS pathways for treating metaplastic breast cancer (MpBC)
Jenny C-N Chang · Methodist Hospital · funded by National Institutes of Health
2022–2024 · research · R21
Molecular basis of decreased susceptibility to beta-lactam antibiotics in Streptococcus pyogenes
James Mallory Musser · Methodist Hospital · funded by National Institutes of Health
2022–2027 · cooperative agreement · U54
The stromal microenvironment as a co-organizer of bladder carcinogenesis and progression
Keith Syson Chan · Methodist Hospital · funded by National Institutes of Health
2022–2027 · research · R01
Ultra-long Acting Transcutaneously Refillable Islatravir Nanofluidic Implant for HIV Pre-Exposure
Alessandro Grattoni · Methodist Hospital · funded by National Institutes of Health
2022–2025 · research · R21
Methods and devices to assist and improve cerebrospinal fluid drainage
Gavin Wayne Britz · Methodist Hospital · funded by National Institutes of Health
2022–2027 · research · R01
Ultra-long Acting Transcutaneously Refillable Islatravir Nanofluidic Implant for HIV Pre-Exposure
Alessandro Grattoni · Methodist Hospital · funded by National Institutes of Health
2022–2027 · research · R01
Mechanisms driving cardiac dysfunction in Autosomal Dominant Polycystic Kidney Disease
Francisco Altamirano · Methodist Hospital · funded by National Institutes of Health
2022–2027 · research · R01
Vascularized NICHE with local immunosuppression for cell replacement for Type 1 diabetes
Alessandro Grattoni · Methodist Hospital · funded by National Institutes of Health
2022–2027 · cooperative agreement · U54
Project-005
Keith Syson Chan · Methodist Hospital · funded by National Institutes of Health
2022–2027 · cooperative agreement · U54
Admin-Core-002
Keith Syson Chan · Methodist Hospital · funded by National Institutes of Health
2022–2027 · cooperative agreement · U54
Project 3
Hideki Furuya · Methodist Hospital · funded by National Institutes of Health
2022–2027 · cooperative agreement · U54
Project 2
Dan Theodorescu · Methodist Hospital · funded by National Institutes of Health
2021–2026 · research · R01
Novel Stem Cell Immunotherapy for MDR-Tuberculosis
Janice J Endsley · Methodist Hospital · funded by National Institutes of Health
2021–2024 · career development · K22
The immunosuppressive function of secretory IgM in tumor-bearing mice
Chih-Hang Anthony Tang · Methodist Hospital · funded by National Institutes of Health
2021–2024 · research · R21
African trypanosome parasites: a new tool to unveil potential immunological strategies to target CLL
Carl De Trez · Methodist Hospital · funded by National Institutes of Health
2021–2022 · research · R56
Novel Determinants of Streptococcus Pyogenes Virulence and Protective Immunity in the Primate Oropharynx: A Genome-wide Strategy
James Mallory Musser · Methodist Hospital · funded by National Institutes of Health
2021–2026 · research · R01
Molecular Mechanism of Virulence Regulation in Streptococcus Pyogenes
Muthiah Kumaraswami · Methodist Hospital · funded by National Institutes of Health